Trinity Biotech reported $-1.3M in Operating Profit for its fiscal quarter ending in December of 2025.





Operating Profit Change Date
Abbott USD 2.13B 281M Jun/2026
Bayer EUR 3.53B 2.42B Mar/2026
Bio-Rad Laboratories USD 72.6M 38.5M Jun/2026
EDAP TMS EUR -7.37M 2.44M Mar/2026
J&J USD 7.48B 860M Jun/2026
Mesa Laboratories USD 5.78M 2.27M Dec/2024
OraSure Technologies USD -13.59M 2.13M Dec/2025
Plus Therapeutics USD -7.12M 1.38M Mar/2026
Roche Holding CHF 11.46B 1.91B Jun/2026
Siemens EUR 3.19B 508M Jun/2026
Thermo Fisher Scientific USD 2.18B 273M Jun/2026
Tosoh JPY 31.18B 5.54B Jun/2026
Trinity Biotech USD -1.3M 796K Dec/2025
Veracyte USD 23.96M 4.88M Jun/2026